Good afternoon :)
Switch to
Place Order

Brooks Laboratories Ltd

BROOKS
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹215 cr, stock is ranked 1,390
Moderate RiskStock is 2.86x as volatile as Nifty
87.200.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹215 cr, stock is ranked 1,390
Moderate RiskStock is 2.86x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-7.89
PB RatioPB Ratio
2.19
Dividend YieldDiv. Yield
Sector PESector PE
69.11
Sector PBSector PB
8.67
Sector Div YldSctr Div Yld
316.33%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201720182019202057.6655.9557.9170.101.67-13.82-14.80-24.37
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Annual Disclosure 
Announced OnApr 25, 2021

Brooks Laboratories Limited has submitted to the Exchange Annual Disclosure as per SEBI Circular dated November 26, 2018. | Download

Brooks Laboratories Limited has submitted to the Exchange Annual Disclosure as per SEBI Circular dated November 26, 2018. | Download

Disclosure under SEBI Takeover Regulations 
Announced OnApr 9, 2021

Promoter/Member of the Promoter Group of the Company has informed the Exchange regarding disclosure under Regulation 30 of SEBI SAST Regulations, 2011 as at March 31, 2021 | Download

Promoter/Member of the Promoter Group of the Company has informed the Exchange regarding disclosure under Regulation 30 of SEBI SAST Regulations, 2011 as at March 31, 2021 | Download

See all events